相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lean non-alcoholic fatty liver disease
Alice Yuxin Wang et al.
CLINICAL NUTRITION (2019)
Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets
Matthew A. Mitsche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort
Peter J. Meffert et al.
JOURNAL OF HEPATOLOGY (2018)
Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: A prospective cohort study
Ming-Feng Xia et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life
Yan Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Stefan Stender et al.
NATURE GENETICS (2017)
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
B. G. P. Koot et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders
M. -F. Xia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The impact of body weight gain on nonalcoholic fatty liver disease and metabolic syndrome during earlier and later adulthood
Shanshan Du et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2016)
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
Marcin Krawczyk et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review
Elina M. Petaja et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial
Eleonora Scorletti et al.
JOURNAL OF HEPATOLOGY (2015)
I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
Jin-Ho Park et al.
LIVER INTERNATIONAL (2015)
Heterogeneity of non-alcoholic fatty liver disease
Hannele Yki-Jarvinen et al.
LIVER INTERNATIONAL (2015)
Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases
Ming-Feng Xia et al.
OBESITY (2015)
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Quentin M. Anstee et al.
SEMINARS IN LIVER DISEASE (2015)
Pnpla3I148M Knockin Mice Accumulate PNPLA3 on Lipid Droplets and Develop Hepatic Steatosis
Eriks Smagris et al.
HEPATOLOGY (2015)
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
Jiayun Shen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Association Between the PNPLA3 (rs738409 C>G) Variant and Hepatocellular Carcinoma: Evidence From a Meta-Analysis of Individual Participant Data
Eric Trepo et al.
HEPATOLOGY (2014)
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method
Ming-Feng Xia et al.
OBESITY (2012)
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design
Xin Gao et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
A Common Variant in the Patatin-Like Phospholipase 3 Gene (PNPLA3) Is Associated with Fatty Liver Disease in Obese Children and Adolescents
Nicola Santoro et al.
HEPATOLOGY (2010)
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent
S. Romeo et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A feed-forward loop amplifies nutritional regulation of PNPLA3
Yongcheng Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene
Konstantinos Kantartzis et al.
DIABETES (2009)
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
Silvia Sookoian et al.
JOURNAL OF LIPID RESEARCH (2009)
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
Lovisa E. Johansson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose
A Festa et al.
DIABETES (2004)
分享论文
